L-cysteine Formulation for Hangover Symptom Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hangover treatments are ineffective due to a lack of scientifically studied ingredients and methods, with many products increasing acetaldehyde toxicity and failing to alleviate symptoms like nausea, headache, and malaise, leading to significant productivity loss and morbidity.
Innovation Solution
A formulation comprising L-cysteine, thiamine, pyridoxine, and optionally ascorbic acid and glucose, administered in specific doses to reduce acetaldehyde accumulation and alleviate hangover symptoms, demonstrated in a double-blind randomized placebo-controlled trial to provide significant symptom relief.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If Pueraria lobata is used as an active ingredient in hangover treatments, then the product can be marketed as a hangover remedy, but it increases acetaldehyde toxicity and produces disulfiram-like reactions
Solution Approach 1:
The patent removes Pueraria lobata from the formulation entirely, extracting the harmful element while retaining the therapeutic intent. The invention substitutes problematic ingredients with safe, effective alternatives that do not produce disulfiram-like reactions or increase acetaldehyde toxicity.
Solution Approach 2:
The patent converts the harmful effect of Pueraria lobata (acetaldehyde accumulation) into a beneficial outcome by using ingredients that actively reduce acetaldehyde levels. L-cysteine and its derivatives are used to enhance acetaldehyde metabolism and elimination, turning the problem of acetaldehyde toxicity into a solution.
2Ease of operation
If commonly available hangover products are used, then symptom relief is sought, but they lack scientific study and proven efficacy
Solution Approach 1:
The patent conducts comprehensive pre-market research and clinical validation before product launch. Multiple studies including systematic reviews, randomized controlled trials, and safety assessments are performed in advance to ensure both efficacy and safety, eliminating the need for post-market testing that characterizes unproven products.
Solution Approach 2:
The patent incorporates continuous feedback from clinical trials and safety monitoring to refine the formulation. Data from multiple independent studies are analyzed to optimize ingredient ratios and dosing regimens, ensuring the product delivers proven results while maintaining safety standards.
3Productivity
If alcohol consumption continues without effective treatment, then social and economic activity continues, but productivity is significantly lost due to hangover symptoms
Solution Approach 1:
The patent enables preventive administration before alcohol consumption or at the onset of hangover symptoms, allowing individuals to maintain productivity throughout the day. The formulation is designed for rapid absorption and action, providing protection or relief before symptoms significantly impact work performance.
Solution Approach 2:
The patent introduces L-cysteine and related compounds as intermediary substances that facilitate acetaldehyde metabolism and elimination. These intermediaries accelerate the body's natural detoxification processes, reducing the duration and severity of hangover symptoms that would otherwise impair productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation significantly improves well-being and alleviates hangover symptoms such as nausea, headache, and desire for greasy foods, with a 177% improvement in primary endpoint well-being scores compared to placebo, showing clinical significance and effectiveness in treating hangover symptoms.
Implementation Method 1
Alcohol is rapidly metabolized to acetaldehyde by the enzyme alcohol dehydrogenase. Acetaldehyde is then metabolized by aldehyde reductase to acetate.
Implementation Method 2
CH3CH2OH+NAD+→CH3CHO+NADH+H+ 1)
Data Source
AI summary
A formulation and a method for treating, preventing or ameliorating or alleviating in a patient the symptoms of hangover, or veisalgia, associated with a bout of excessive alcohol consumption are disclosed. More specifically, a formulation comprising L-cysteine, thiamine and pyridoxine and a method for treating, preventing, ameliorating, or alleviating in a patient one or more of the symptoms of nausea, headache, diminished concentration, malaise and/or tiredness, and a desire to consume greasy and/or fatty and/or oily foods, associated with a bout of excessive alcohol consumption are disclosed.